Life Science Washington is helping founders strengthen investor messaging while promoting Seattle’s position as a leading hub for AI-driven biotechnology.
Marc Cummings highlighted the growing role of artificial intelligence in the region’s innovation ecosystem, noting that new AI tools can “lower the cost and accelerate the pace” of discovery, while pointing to the state’s $41.2 billion life sciences sector, leading research institutions like the University of Washington’s Institute for Protein Design, and increasing collaboration between biotech and major technology companies. He also emphasized workforce and policy dynamics shaping continued growth.
For Seattle, a top 10 biotech cluster in the U.S., strengthening connections between biotech and AI alongside clearer storytelling could help unlock faster innovation and greater investment.